| Report ID |
163664 |
| Drug Identification Number |
02294346 |
| Brand name |
APIDRA |
| Common or Proper name |
Apidra Solostar |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
INSULIN GLULISINE |
| Strength(s) |
100UNIT |
| Dosage form(s) |
SOLUTION |
| Route of administration |
SUBCUTANEOUS
SUBCUTANEOUS |
| Packaging size |
5 |
| ATC code |
A10AB |
| ATC description |
INSULINS AND ANALOGUES |
| Reason for shortage |
Delay in shipping of the drug. |
| Anticipated start date |
2022-07-04 |
| Actual start date |
2022-07-07 |
| Estimated end date |
2022-09-23 |
| Actual end date |
2022-09-23 |
| Shortage status |
Resolved |
| Updated date |
2022-09-26 |
| Company comments |
The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
